Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052248892> ?p ?o ?g. }
- W2052248892 endingPage "109" @default.
- W2052248892 startingPage "59" @default.
- W2052248892 abstract "Terrestrial animals must conserve water and NaCl to survive dry environments. The kidney reabsorbs 95% of the sodium filtered from the glomeruli before sodium reaches the distal connecting tubules. Excess sodium intake requires the renal kallikrein-kinin system for additional excretion. Renal kallikrein is secreted from the distal connecting tubule cells of the kidney, and its substrates, low molecular kininogen, from the principal cells of the cortical collecting ducts (CD). Formed kinins inhibit reabsorption of NaCl through bradykinin (BK)-B2 receptors, localized along the CD. Degradation pathway of BK by kinin-destroying enzymes in urine differs completely from that in plasma, so that ACE inhibitors are ineffective. Urinary BK is destroyed mainly by a carboxypeptidase-Y-like exopeptidase (CPY) and partly by a neutral endopeptidase (NEP). Inhibitors of CPY and NEP, ebelactone B and poststatin, respectively, were found. Renal kallikrein secretion is accelerated by potassium and ATP-sensitive potassium (KATP) channel blockers, such as PNU-37883A. Ebelactone B prevents DOCA-salt hypertension in rats. Only high salt intake causes hypertension in animals deficient in BK-B2 receptors, tissue kallikrein, or kininogen. Hypertensive patients, and spontaneously hypertensive rats, excrete less kallikrein than normal subjects, irrespective of races, and become salt-sensitive. Ebelactone B, poststatin, and KATP channel blockers could become novel antihypertensive drugs by increase in urinary kinin levels. Roles of kinin in cardiovascular diseases were discussed." @default.
- W2052248892 created "2016-06-24" @default.
- W2052248892 creator A5001289757 @default.
- W2052248892 creator A5086946546 @default.
- W2052248892 date "2010-01-07" @default.
- W2052248892 modified "2023-10-17" @default.
- W2052248892 title "A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept" @default.
- W2052248892 cites W101975661 @default.
- W2052248892 cites W126677923 @default.
- W2052248892 cites W1513280988 @default.
- W2052248892 cites W1599015076 @default.
- W2052248892 cites W1607236619 @default.
- W2052248892 cites W1870534745 @default.
- W2052248892 cites W189079880 @default.
- W2052248892 cites W1901938119 @default.
- W2052248892 cites W1912446096 @default.
- W2052248892 cites W1964033888 @default.
- W2052248892 cites W1964315955 @default.
- W2052248892 cites W1964852661 @default.
- W2052248892 cites W1965077308 @default.
- W2052248892 cites W1965952910 @default.
- W2052248892 cites W1966102491 @default.
- W2052248892 cites W1966406818 @default.
- W2052248892 cites W1966682053 @default.
- W2052248892 cites W1967329047 @default.
- W2052248892 cites W1968355348 @default.
- W2052248892 cites W1968402169 @default.
- W2052248892 cites W1968727207 @default.
- W2052248892 cites W1968948768 @default.
- W2052248892 cites W1969130635 @default.
- W2052248892 cites W1969343323 @default.
- W2052248892 cites W1969525057 @default.
- W2052248892 cites W1970319400 @default.
- W2052248892 cites W1971094372 @default.
- W2052248892 cites W1973033392 @default.
- W2052248892 cites W1973651070 @default.
- W2052248892 cites W1975204364 @default.
- W2052248892 cites W1975861373 @default.
- W2052248892 cites W1976880237 @default.
- W2052248892 cites W1976887287 @default.
- W2052248892 cites W1979615536 @default.
- W2052248892 cites W1979861748 @default.
- W2052248892 cites W1980413731 @default.
- W2052248892 cites W1980861089 @default.
- W2052248892 cites W1981372032 @default.
- W2052248892 cites W1985629934 @default.
- W2052248892 cites W1986905765 @default.
- W2052248892 cites W1989737670 @default.
- W2052248892 cites W1989982905 @default.
- W2052248892 cites W1990299655 @default.
- W2052248892 cites W1993035055 @default.
- W2052248892 cites W1993487455 @default.
- W2052248892 cites W1997812290 @default.
- W2052248892 cites W1997844820 @default.
- W2052248892 cites W1998014245 @default.
- W2052248892 cites W1998888535 @default.
- W2052248892 cites W2000855130 @default.
- W2052248892 cites W2001207560 @default.
- W2052248892 cites W2002135070 @default.
- W2052248892 cites W2002294257 @default.
- W2052248892 cites W2002563649 @default.
- W2052248892 cites W2003201080 @default.
- W2052248892 cites W2003625263 @default.
- W2052248892 cites W2005123294 @default.
- W2052248892 cites W2006689292 @default.
- W2052248892 cites W2006712690 @default.
- W2052248892 cites W2009890346 @default.
- W2052248892 cites W2010485644 @default.
- W2052248892 cites W2011021180 @default.
- W2052248892 cites W2011699421 @default.
- W2052248892 cites W2016836925 @default.
- W2052248892 cites W2017107588 @default.
- W2052248892 cites W2018208503 @default.
- W2052248892 cites W2020214606 @default.
- W2052248892 cites W2020385191 @default.
- W2052248892 cites W2020670793 @default.
- W2052248892 cites W2021490640 @default.
- W2052248892 cites W2022612342 @default.
- W2052248892 cites W2022919113 @default.
- W2052248892 cites W2024496351 @default.
- W2052248892 cites W2025003289 @default.
- W2052248892 cites W2025540579 @default.
- W2052248892 cites W2025562266 @default.
- W2052248892 cites W2026563231 @default.
- W2052248892 cites W2026826353 @default.
- W2052248892 cites W2027122905 @default.
- W2052248892 cites W2028599952 @default.
- W2052248892 cites W2029678430 @default.
- W2052248892 cites W2033402026 @default.
- W2052248892 cites W2033829789 @default.
- W2052248892 cites W2034413625 @default.
- W2052248892 cites W2035493971 @default.
- W2052248892 cites W2037314635 @default.
- W2052248892 cites W2037381400 @default.
- W2052248892 cites W2039031569 @default.
- W2052248892 cites W2040156575 @default.
- W2052248892 cites W2042138249 @default.
- W2052248892 cites W2044485644 @default.